{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-062681","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.224343+00:00","generated_at":"2026-06-14T19:29:39.049518+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Collegium shareholders elect all nine directors, approve say-on-pay, ratify auditor","bullets":["All nine director nominees re-elected; votes ranged from 25.9M to 28.3M for, with broker non-votes of ~2.46M.","Advisory say-on-pay approved with 27,953,926 for, 315,383 against, 90,502 abstentions.","Ratification of Deloitte & Touche as independent auditor for FY2023 passed with 30,742,534 for, 44,006 against, 29,155 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-062681","json":"https://secwatch.observer/filing/0001104659-23-062681.json","markdown":"https://secwatch.observer/filing/0001104659-23-062681.md","text":"https://secwatch.observer/filing/0001104659-23-062681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/tm2316254d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T19:29:39.049518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17b9ebef7f415172c69af520c5740726818d1820","claim":"COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of nine Directors to hold office until the 2024 Annual Meeting of Shareholders.","evidence_excerpt":"Each of Rita Balice-Gordon, Garen Bohlin, Joseph Ciaffoni, John Fallon, John Freund, Michael Heffernan, Neil F. McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2024 Annual Meeting of Shareholders.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"31f1e40188b3398c535d2ef5c44e91acf046b068","claim":"COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers.","evidence_excerpt":"On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"e6cd91ddea597df1c48c0eab0b8fe46cb29497be","claim":"COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_excerpt":"Proposal 3 was approved by the Company's shareholders.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}